SavedAdd your journal

Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 3

Evaluation of relationship among polycystic ovarysyndrome, atherogenic index of plasma, and highsensitive C reactive protein

Emre Atay
Ayhan Vurmaz
Selvihan Beysel
Serkan Gökaslan
Erhan Bozkurt
Ayşe Ertekin
Pages
564–570
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: AIP and hs-CRP levels were higher in PCOS group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, we aimed to investigate the relationship among cardiovascular risk factors (CRFs), atherogenic index of plasma(AIP) and high-sensitivity C-reactive protein (hs-CRP) levels in polycystic ovary syndrome (PCOS) patients and identify risks earlier.Materials and Methods: 131 patients diagnosed with PCOS according to Rotterdam criteria and 140 healthy controls were includedfrom August 2019 to October 2019.
📊
Key Findings & Data:Blood samples were done in the early follicular phase of the patients and were done after 10-12hours of fasting.
💡
Conclusion & Impact:Results: AIP and hs-CRP levels were higher in PCOS group (p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: In this study, we aimed to investigate the relationship among cardiovascular risk factors (CRFs), atherogenic index of plasma(AIP) and high-sensitivity C-reactive protein (hs-CRP) levels in polycystic ovary syndrome (PCOS) patients and identify risks earlier.Materials and Methods: 131 patients diagnosed with PCOS according to Rotterdam criteria and 140 healthy controls were includedfrom August 2019 to October 2019. Blood samples were done in the early follicular phase of the patients and were done after 10-12hours of fasting. Results: AIP and hs-CRP levels were higher in PCOS group (p

🔖

Cite This Article

Atay, E., Vurmaz, A., Beysel, S., Gökaslan, S., Bozkurt, E., Ertekin, A. (2022). Evaluation of relationship among polycystic ovarysyndrome, atherogenic index of plasma, and highsensitive C reactive protein. Annals of Medical Research, Cilt: 28 - Sayı: 3, 564–570. https://ajindex.com/articles/445879

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Morgante G, Massaro MG, Di Sabatino A, et al. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecol Endocrinol 2018;34:4-9
  2. Sova H, Unkila-Kallio L, Tiitinen A, et al. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes. Gynecol Endocrinol 2019;35:595-600
  3. Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and metaAnalysis. Hum Reprod 2016;31:2841-55
  4. Wild RA. Polycystic ovary syndrome: A risk for coronary artery disease? Am J Obstet Gynecol 2002;186:35-43
  5. Carmina E. Cardiovascular risk and events in polycystic ovary syndrome. Climacteric 2009;12:22-5
  6. Lo JC, Feigenbaum SL, Yang J, et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:1357-63
  7. Parinita K. of serum lipid profile in individuals residing in and around Nalgonda. Int J Pharm Bio Sci 2012;2:110-6
  8. Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998;81:18-25
  9. Talbott EO, Zborowski J V., Boudreaux MY, et al. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004;89:6061-6
  10. Orio F, Palomba S, Cascella T, et al. Early impairment of endothelial structure and function in young normalweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004;89:4588-93
  11. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev 2003;24:313-40
  12. Dobiášová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate inapoblipoprotein-depleted plasma (FERHDL). Clin Biochem 2001;34:583-8
  13. Haverkate F, Thompson SG, Pyke SDM, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462-6
  14. Report of a WHO consultation. Obesity: preventing and managing the global epidemic. WHO Library Cataloguing-in-Publication Data, Geneva, 2000
  15. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III